Marsden John, Farrell Michael, Bradbury Colin, Dale-Perera Annette, Eastwood Brian, Roxburgh Malcolm, Taylor Steve
Division of Psychological Medicine and Psychiatry, Institute of Psychiatry (King's College London), 4 Windsor Walk, London, UK.
Addiction. 2008 Sep;103(9):1450-60. doi: 10.1111/j.1360-0443.2008.02284.x.
To develop the Treatment Outcomes Profile (TOP), a new instrument for monitoring substance misuse treatment.
Prospective cohort, psychometric evaluation with 7-day retest and 1-month follow-up to assess inter-rater reliability, concurrent, discriminant and construct validity, and change sensitivity.
A sample of 1021 service users, aged 16-62 years. Recruitment from 63 treatment agencies in England, collectively providing opioid substitution treatment, psychosocial interventions, in-patient detoxification and residential rehabilitation.
Thirty-eight frequency, rating scale and period prevalence measures, with 28-day recall, across substance use, health, crime and social functioning domains, administered as personal interview by 163 treatment keyworkers.
Twenty outcome measures met inter-rater reliability criteria: days used alcohol, opioids, crack cocaine, cocaine powder, amphetamines, cannabis and one other named substance; days injected and period prevalence of direct or indirect needle/syringe sharing; subjective rating of physical and psychological health; days committed shop theft and drug selling, period prevalence of vehicle, property, fraud/forgery and assault/violence offences; rating of quality of life; days worked and attended for education/training; and period prevalence of acute housing problems and risk of eviction. Intraclass correlation coefficients for scale measures and Cohen's kappa for dichotomous measures reached or exceeded 0.75 and 0.61, respectively. There were satisfactory validity assessments and change sensitivity of scale items judged by effect size and smallest detectable difference. The TOP clinical tool contains an additional 10 items for individual treatment planning and review.
The TOP is a reliable and valid 20-item instrument for treatment outcomes monitoring.
开发治疗结果概况(TOP),一种用于监测药物滥用治疗的新工具。
前瞻性队列研究,进行心理测量评估,包括7天复测和1个月随访,以评估评分者间信度、同时效度、区分效度和结构效度以及变化敏感性。
1021名年龄在16至62岁之间的服务使用者样本。从英格兰的63个治疗机构招募,这些机构共同提供阿片类药物替代治疗、心理社会干预、住院戒毒和住院康复服务。
38项频率、评分量表和时期患病率测量指标,采用28天回忆法,涵盖药物使用、健康、犯罪和社会功能领域,由163名治疗关键工作人员进行个人访谈。
20项结果指标符合评分者间信度标准:饮酒、使用阿片类药物、快克可卡因、可卡因粉、苯丙胺、大麻以及另一种指定药物的天数;注射天数以及直接或间接共用针头/注射器的时期患病率;身心健康的主观评分;商店盗窃和毒品销售天数、车辆、财产、欺诈/伪造和袭击/暴力犯罪的时期患病率;生活质量评分;工作天数和参加教育/培训天数;以及急性住房问题时期患病率和被驱逐风险。量表测量的组内相关系数和二分变量测量的科恩kappa系数分别达到或超过0.75和0.61。根据效应大小和最小可检测差异判断,量表项目具有令人满意的效度评估和变化敏感性。TOP临床工具还包含另外10项用于个体治疗计划和评估的项目。
TOP是一种可靠且有效的20项工具,用于治疗结果监测。